Disruption of immune cells in blood is linked to cancer outcomes, new tool reveals

Updated on: April 29,2025

Disruption of immune cells in blood is linked to cancer outcomes, new tool reveals

Updated on:April 29,2025

Women more prone to selected oesophagogastric cancer chemotherapy side-effects

byEuropean Society for Medical OncologyMen and women may need to be treated differently—at least when it comes to some types of cancer. In an analysis (1) to be presented at the ESMO 2018 Congre

Updated on: December 18,2023

Women more prone to selected oesophagogastric cancer chemotherapy side-effects

byEuropean Society for Medical OncologyMen and women may need to be treated differently—at least when it comes to some types of cancer. In an analysis (1) to be presented at the ESMO 2018 Congre

Updated on:December 18,2023

Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

by SWOG Cancer Research NetworkCredit: CC0 Public DomainFindings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obs

Updated on: January 04,2024

Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

by SWOG Cancer Research NetworkCredit: CC0 Public DomainFindings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obs

Updated on:January 04,2024

Study examines treatment options for women with recurrent ovarian cancer

by WileyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epit

Updated on: June 01,2024

Study examines treatment options for women with recurrent ovarian cancer

by WileyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epit

Updated on:June 01,2024

Breast density notification laws not effective for all women

byYale UniversityA new study suggests that state-mandated notifications on mammogram reports intended to inform women of the health risks related to breast density are not worded effectively.The

Updated on: December 20,2023

Breast density notification laws not effective for all women

byYale UniversityA new study suggests that state-mandated notifications on mammogram reports intended to inform women of the health risks related to breast density are not worded effectively.The

Updated on:December 20,2023

Study findings provide new insight into how breast cancer evolves

by Kyoto UniversityThe der(1;16) translocation-positive breast cancer originated from a single cell around puberty. This cell repeatedly underwent cell division and expanded until it developed in

Updated on: February 20,2024

Study findings provide new insight into how breast cancer evolves

by Kyoto UniversityThe der(1;16) translocation-positive breast cancer originated from a single cell around puberty. This cell repeatedly underwent cell division and expanded until it developed in

Updated on:February 20,2024

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung

Updated on: May 09,2024

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung

Updated on:May 09,2024

CAR T cell therapy: On the cusp of 'an immunotherapy revolution'?

by Delthia Ricks , Medical XpressCancer cell during cell division. Credit: National Institutes of HealthA deeper understanding of the immune system's role in controlling cancer has helped drive &q

Updated on: April 09,2024

CAR T cell therapy: On the cusp of 'an immunotherapy revolution'?

by Delthia Ricks , Medical XpressCancer cell during cell division. Credit: National Institutes of HealthA deeper understanding of the immune system's role in controlling cancer has helped drive &q

Updated on:April 09,2024

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis

Updated on: June 22,2024

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis

Updated on:June 22,2024

How genome doubling helps cancer develop

byEcole Polytechnique Federale de LausanneChromosomes in cells with whole genome doubling. Credit: Elisa Oricchio/Giovanni Ciriello (EPFL/UNIL)A single cell contains 2-3 meters of DNA, meaning t

Updated on: December 25,2023

How genome doubling helps cancer develop

byEcole Polytechnique Federale de LausanneChromosomes in cells with whole genome doubling. Credit: Elisa Oricchio/Giovanni Ciriello (EPFL/UNIL)A single cell contains 2-3 meters of DNA, meaning t

Updated on:December 25,2023

Exploring the role of reactive oxygen species in cellular health and disease through HyPerion

Updated on: July 17,2024

Exploring the role of reactive oxygen species in cellular health and disease through HyPerion

Updated on:July 17,2024

Study describes treatment of secondary CNS involvement by aggressive lymphomas

by Sylvester Comprehensive Cancer CenterHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Some patients with aggressive lymphomas

Updated on: June 28,2024

Study describes treatment of secondary CNS involvement by aggressive lymphomas

by Sylvester Comprehensive Cancer CenterHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Some patients with aggressive lymphomas

Updated on:June 28,2024